Nucleolin Targeting AS1411 Modified Protein Nanoparticle for Antitumor Drugs Delivery

Wu, Jinhui, Song, Chenchen, Jiang, Chenxiao, Shen, Xin, Qiao, Qian, Hu, Yiqiao·2013·Molecular Pharmaceutics

Cited by (125)

Items 101–125 of 125

  1. Status and Prospects of Aptamers as Drug Components
    Christopher Mattice, Maria C. DeRosa · 2015 · BioDrugs
  2. A fluorescent immunosensor for determination and imaging of circulating tumor cells based on a bifunctional DNA nanomachine
    Ye Zhang, Shihua Luo, Bo Situ, Xinyi Ye, Yifang Huang, Bo Li, Xiujuan Jiang, Xueping Chen, Lei Zheng, Xiaohui Yan · 2020 · Microchimica Acta
  3. Enhanced Glioblastoma Selectivity of Harmine via the Albumin Carrier
    Shihui Liu, Qing-Zhen Wang, Tao Liu, Ru Bai, Man-Man Ma, Qiaolin Liu, Huige Zhou, Jing Liu, Mei Wang · 2022 · Journal of Biomedical Nanotechnology
  4. Nucleic acid biohybrid nanocarriers with high‐therapeutic payload and controllable extended release of daunomycin for cancer therapy
    Ricky Whitener, Robert J. Mosley, Jacek Wower, Mark Edward Byrne · 2020 · Journal of Biomedical Materials Research Part A
  5. Exploiting the Catalytic Ability of Polydopamine-Remodeling Gold Nanoparticles toward the Naked-Eye Detection of Cancer Cells at a Single-Cell Level
    Bo-Zhao Yang, Zheng‐Yuan Su, Amily Fang‐Ju Jou · 2021 · ACS Applied Bio Materials
  6. Aptamer-Engineered Cu2O Nanocubes as a Surface-Modulated Catalytic Optical Sensor for Lung Cancer Cell Detection
    Amily Fang‐Ju Jou, Yu-Chieh Hsu · 2022 · ACS Applied Bio Materials
  7. A molecular hybrid comprising AS1411 and PDGF‐BB aptamer, cholesterol, and doxorubicin for inhibiting proliferation of SW480 cells
    Pichayanoot Rotkrua, Walaiporn Lohlamoh, Paphada Watcharapo, Boonchoy Soontornworajit · 2021 · Journal of Molecular Recognition
  8. The Effect of AS1411 Surface Density on The Tumor Targeting Properties of Pegylated Silver Nanotriangles
    Yuyu Cao, Huiquan Yang, Dong‐Dong Li, Fan Li, Jing Ma, Peidang Liu · 2022 · Nanomedicine
  9. Anti-nucleolin Aptamer as a Boom in Rehabilitation of Breast Cancer
    S.K. Janani, S. P. Dhanabal, R. Sureshkumar, Sai Surya Nikitha Upadhyayula · 2022 · Current Pharmaceutical Design
  10. Applications of Aptamers in Cancer Therapy
    Ajda Çoker Gürkan, Pınar Obakan Yerlikaya, Elif Damla Arısan · 2018 · InTech eBooks
  11. Design and functionalization of micelle-embedded polymeric films: Reactive platforms for controlled and targeted drug delivery
    Rizwana Fathima M. Kasim, Kalaivizhi Rajappan · 2025 · Reactive and Functional Polymers
  12. Benchmarking Protein Nanoparticles for Drug Delivery and Clinical Translation
    Han Sol Lee, Suwon Choo, Mansingh Chaudhary, Ju Hee Park, Juhwan Chang, Y. Byun, Ki‐taek Kim, Jae‐Young Lee · 2025 · Small Methods
  13. Liposome as nanocarrier: Site targeted delivery in lung cancer
    N. Ullah, Saba C. Saba Noreen, K. Tehreem, A. Zaman, Z. Ahmad, Humaira Balouch, N. Samad · 2017 · Asian Pacific Journal of Tropical Disease
  14. Polypod-like structured guanine-rich oligonucleotide aptamer as a selective and cytotoxic nanostructured DNA to cancer cells
    Kohta Mohri, Emi Hayashi, Manato Nishino, Nao Matsushita, Sohei Tanishita, Makiya Nishikawa, Shinji Sakuma · 2020 · Journal of drug targeting
  15. Self-assembled protein-drug nanoparticles for enhanced drug delivery and targeting cancer therapeutics
    Islam A. Hassanin, Mohamed Teleb, Adnan A. Bekhit, Kadria A. Elkhodairy, Sherine N. Khattab, Ahmed O. Elzoghby · 2023 · Elsevier eBooks
  16. Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas
    Dawn R. Cochrane, Gian Luca Negri, Jutta K. Huvila, Forouh Kalantari, David Farnell, Nissreen Mohammad, Emily Thompson, Winnie Yang, Amy M. Lum, Sandra E. Spencer Miko et al. · 2025 · Neoplasia
  17. A variation in thiophene-extended nucleosides as microenvironment-sensitive fluorescent probes
    Tomotaka Kumagai, Tatum Melati Andini, Hiroshi Sugiyama, Daron M. Standley, Soyoung Park · 2026 · Sensors and Actuators B Chemical
  18. Development of AS1411 aptamer-conjugated chitosan-carbon dot nanocarriers for targeted drug delivery and fluorescent imaging in breast cancer therapy
    Mohammad Jafar Mantashlou, Effat Alizadeh, Sevil Vaghefi Moghaddam, Neda Saraygord‐Afshari, Amir Noorbakhsh · 2026 · Journal of Biological Engineering
  19. Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review
    Luana Di Leandro, Martina Colasante, Mariano Catanesi, Francesco Giansanti, Annamaria Cimini, Michele d’Angelo, Vanessa Castelli, Rocco Savino, Rodolfo Ippoliti · 2026 · International Journal of Molecular Sciences
  20. Aptamer-Mediated Selective Protein Affinity to Improve Scaffold Biocompatibility
    Ludovica Parisi, Carlo Galli, Lisa Elviri, Annalisa Bianchera, Paola Lagonegro, Simone Lumetti, Edoardo Manfredi, Guido Maria Macaluso · 2016 · InTech eBooks
  21. Nanoparticles Targeting and Uptake: Current Advances in Breast Cancer Research
    Onila Lugun, Alok Kumar Pandey · 2022 · BENTHAM SCIENCE PUBLISHERS eBooks
  22. Dissecting the tRNA Fragment tRF3E–Nucleolin Interaction: Implications in Breast Cancer
    Maurizio Falconi, Junbiao Wang, Andrea Costamagna, Mara Giangrossi, Sunday Segun Alimi, Emilia Turco, Massimo Bramucci, Luana Quassinti, Rossana Petrilli, Michela Buccioni et al. · 2025 · Biomolecules
  23. Proteomic Characterization of AS1411 Reveals ATP6AP1 as a Mediator of Triple‐Negative Breast Cancer Progression
    Ha-Song Bae, Yun‐Jeong Seo, Eun‐Bi Kim, Hyoung‐Min Park, I‐Hsuan Liu, J. Eugene Lee, Jae‐Young Kim · 2026 · PROTEOMICS
  24. Développement d'architectures foldamères comme systèmes de transport originaux de biomolécules.
    Mégane Bornerie · 2019
  25. AS1411 Aptamer–Nucleolin Axis in Cancer: Mechanisms, Therapeutic Potential, and Clinical Challenges
    Kruthika Prakash, Janani Balaji, Kandasamy Nagarajan ArulJothi · 2026 · Current Pharmacology Reports